YOURGENE HEALTH  LS 0,001
YOURGENE HEALTH LS 0,001
Share · GB00BN31ZD89 · A116JH (XLON)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -97,22 %

Company Profile for YOURGENE HEALTH LS 0,001 Share

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.

Company Data

Name YOURGENE HEALTH LS 0,001
Company Yourgene Health Plc
Website https://www.yourgene-health.com
Primary Exchange XLON London
WKN A116JH
ISIN GB00BN31ZD89
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Lyn Dafydd Rees
Market Capitalization 16 Mio
Country United Kingdom
Currency GBP
Employees 0,3 T
Address Citylabs 1.0, M13 9NQ Manchester
IPO Date 2002-05-21

Stock Splits

Date Split
04.07.2014 1:100

Ticker Symbols

Name Symbol
London YGEN.L

More Shares

Investors who YOURGENE HEALTH LS 0,001 hold also have the following shares in their portfolio:
LB.HESS.THR.CARRARA06R/18
LB.HESS.THR.CARRARA06R/18 Bond
TALANX AG NACHR.MTN 21/42
TALANX AG NACHR.MTN 21/42 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025